Tenax Therapeutics (TENX) Free Cash Flow (2016 - 2017)
Historic Free Cash Flow for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to -$1.3 million.
- Tenax Therapeutics' Free Cash Flow rose 5871.04% to -$1.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$12.1 million, marking a year-over-year increase of 2349.18%. This contributed to the annual value of -$14.8 million for FY2024, which is 15086.38% down from last year.
- Tenax Therapeutics' Free Cash Flow amounted to -$1.3 million in Q4 2017, which was up 5871.04% from -$1.2 million recorded in Q3 2017.
- Tenax Therapeutics' Free Cash Flow's 5-year high stood at -$1.2 million during Q3 2017, with a 5-year trough of -$65.3 million in Q1 2014.
- In the last 5 years, Tenax Therapeutics' Free Cash Flow had a median value of -$3.6 million in 2015 and averaged -$16.0 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 9534.58% in 2014, then plummeted by 9469.87% in 2015.
- Quarter analysis of 5 years shows Tenax Therapeutics' Free Cash Flow stood at -$62.6 million in 2013, then soared by 95.35% to -$2.9 million in 2014, then tumbled by 32.52% to -$3.9 million in 2015, then rose by 19.55% to -$3.1 million in 2016, then surged by 58.71% to -$1.3 million in 2017.
- Its last three reported values are -$1.3 million in Q4 2017, -$1.2 million for Q3 2017, and -$5.6 million during Q2 2017.